HOME >> BIOLOGY >> NEWS
Gateway to Nanoscience: The convergence of disciplines

in discussions. The European Commissioner for Science and Research, Janez POTOCNIK, will give a key note speech to emphasize the need of research in this field. The conference will be officially opened by Francesco Fedi, President of the COST Committee of Senior Officials; Martin Grabert, COST Director; Philippe Busquin, MEP and Ian Halliday, President of ESF.

Further the forum provides the unique chance to interview outstanding scientists, such as: - Tomasz DIETL, Polish Academy of Sciences, Warszawa (PL): he has been awarded the Agilent Technologies Europhysics Prize (2005) and will be speaking about "The Emerging Nano-Materials World". - Ruth DUNCAN, Cardiff University (UK): as leading researcher in Nanotechnology in Medicine, she will summarise the latest achievements "Towards improved Diagnosis and Treatment" - Gran HERMERN, Lund University (SE), President of the European Group on Ethics in Science and New Technologies will reflect on "What are the ethical issues around the perceived risks of nanoscience?" - John Ryan , Professor of Physics and Director of the Bionanotechnology Interdisciplinary Research Centre at Oxford University. His current research ranges from single molecule studies of membrane proteins to hybrid bio-nano devices and applications in nanomedicine.

These experts are available for one-to-one interviews. Just reply by e-mail and inform us if you will attend the Forum and whom you would like to speak to.

Where & When:

European Forum on Nanosciences : A Converging Approach Across Disciplines, 19-20 October 2006 Venue: Charlemagne Building, Rue de la Loi 170, room CHA S3 Brussels, Belgium


'"/>

Contact: Gabi Egartner
gegartner@cost.esf.org
322-533-3803
European Science Foundation
3-Oct-2006


Page: 1 2

Related biology news :

1. Full-year results from Oxford Open show wide variation in open access uptake across disciplines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: